NYSE:ASPNChemicals
Aspen Aerogels (ASPN): Evaluating Valuation After Lowered 2025 Outlook and Larger Projected Net Loss
Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger annual net loss, including a hefty impairment charge.
See our latest analysis for Aspen Aerogels.
It’s been a punishing year for Aspen Aerogels after a string of disappointing results and lowered guidance. The share price has tumbled 65% in the last month, and the one-year total shareholder...